PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as the potential treatment of lymphedema, and other ... Read More
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as the potential treatment of lymphedema, and other ... Read More